Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
4.670
+0.250 (5.66%)
Aug 21, 2026, 11:21 AM EDT - Market open
Armata Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Armata Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $17.5. The average 1-year stock price forecast is 274.73% higher than the current stock price, while the lowest is $15 (+221.20%) and the highest is $20 (+328.27%).
Price Target: $17.5 (+274.73%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Armata Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $15 | Buy | Reiterates | $15 | +221.20% | Aug 13, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $20 | Buy | Reiterates | $20 | +328.27% | May 28, 2026 |
Financial Forecast
Revenue This Year
800.00K
from 4.90M
Decreased by -83.69%
Revenue Next Year
2.75M
from 800.00K
Increased by 243.75%
EPS This Year
-0.82
from -1.31
EPS Next Year
-0.59
from -0.82
EPS and Forward PE are based on non-GAAP adjusted numbers.